Peroxisome proliferator-activated receptor-gamma calls for activation in moderation: lessons from genetics and pharmacology.
about
An oxidized lipid-peroxisome proliferator-activated receptor gamma-chemokine pathway in the regulation of macrophage-vascular smooth muscle cell adhesionNatural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a reviewEndocrine-disrupting chemicals: an Endocrine Society scientific statementMitochondrial targets for pharmacological intervention in human diseaseT2384, a novel antidiabetic agent with unique peroxisome proliferator-activated receptor gamma binding propertiesPomegranate flower: a unique traditional antidiabetic medicine with dual PPAR-alpha/-gamma activator propertiesGraves' ophthalmopathyFrom estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosisPharmacogenomics of Drug Response in Type 2 Diabetes: Toward the Definition of Tailored Therapies?Are thiazolidinediones good or bad for the heart?Ppargamma2 is a key driver of longevity in the mouse.Transcriptional profiling of mesenchymal stromal cells from young and old rats in response to Dexamethasone.Association of PPARgamma allelic variation, osteoprotegerin and abdominal aortic aneurysmEpigenetic silencing of peroxisome proliferator-activated receptor γ is a biomarker for colorectal cancer progression and adverse patients' outcome.Peroxisome proliferator-activated receptor-gamma mediates bisphenol A inhibition of FSH-stimulated IGF-1, aromatase, and estradiol in human granulosa cells.Novel PPARγ partial agonists with weak activity and no cytotoxicity; identified by a simple PPARγ ligand screening system.The Pro12Ala Polymorphism of PPAR-γ Gene Is Associated with Sepsis Disease Severity and Outcome in Chinese Han Population.PPARG: Gene Expression Regulation and Next-Generation Sequencing for Unsolved Issues.Use of small interfering ribonucleic acids to inhibit the adipogenic effect of alcohol on human bone marrow-derived mesenchymal cellsDisordered lipid metabolism and the pathogenesis of insulin resistance.Pro12Ala polymorphism of the peroxisome proliferator-activated receptor γ2 in patients with fatty liver diseases.Effects of PPARγ and RBP4 gene variants on metabolic syndrome in HIV-infected patients with anti-retroviral therapyPeroxisome proliferator-activated receptors as stimulants of angiogenesis in cardiovascular disease and diabetes.Caloric restriction and growth hormone receptor knockout: effects on expression of genes involved in insulin action in the heart.Modulation of adipocyte lipogenesis by octanoate: involvement of reactive oxygen species.Prevalence of the Pro12Ala missense mutation in the PPARG2 gene in Kuwaiti patients with primary knee osteoarthritisThe Genetics of PPARG and the Skeleton.Oncogenic steroid receptor coactivator-3 is a key regulator of the white adipogenic program.PPARgamma-independent increase in glucose uptake and adiponectin abundance in fat cells.Identification of a novel selective agonist of PPARγ with no promotion of adipogenesis and less inhibition of osteoblastogenesis.Perinatal nicotine exposure suppresses PPARγ epigenetically in lung alveolar interstitial fibroblasts.Association of polymorphisms in the peroxisome proliferator-activated receptor gamma gene and osteoarthritis of the kneeActivation of peroxisome proliferator-activated receptor gamma contributes to the survival of T lymphoma cells by affecting cellular metabolism.PPARγ mRNA in the adult mouse hypothalamus: distribution and regulation in response to dietary challenges.Evaluation of proinflammatory cytokines and inflammation markers as biomarkers for the action of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers.Peroxisome proliferator-activated receptor gamma: the more the merrier?PPARgamma in human and mouse physiologyGenes involved in obesity: Adipocytes, brain and microfloraThe toxicology of ligands for peroxisome proliferator-activated receptors (PPAR).Obesity drugs and their targets: correlation of mouse knockout phenotypes with drug effects in vivo.
P2860
Q24300694-DB7D5066-5CA6-4D03-B241-AD4D54D1DDD8Q24561401-7F035B0B-7A98-4FDC-BBC3-9D2D27BFF42DQ24651457-92D77102-09B6-4F52-B7BE-3E647B0DB514Q26824514-17C78BE2-BC74-47BF-A666-B745D5BEB5CFQ27649827-60762CF3-14C7-4CF3-A8C9-C4C10C272DE5Q28261771-24A7D8FD-56C7-4A7C-9F5F-A54ECCE8F148Q28274196-702C7B78-ABED-4DA3-A9F6-78AB4D7EEADBQ28385120-8E8C4E7B-0CEB-4242-9E25-E01E88769F11Q30388214-EC41A35C-037D-4087-9FDB-FB3CBBF88B77Q30435005-2543526E-BFEA-41B3-83F9-00BBC4182AA5Q30975227-9D208B49-C6DE-4091-97B9-69DC85D61B60Q33241387-6AA11965-8A4B-478E-9893-939B4DD36404Q33575645-62750BB7-D0A0-4280-AA2C-1908A8BD69E1Q33769492-2D900654-EA5B-41B4-8F6A-40A8A67F9BC3Q33789946-1679210D-7945-4483-998A-338EC539E44BQ33935032-ABF07771-0133-407A-9F09-70F50A547735Q34038160-382883E7-AA9E-49DC-8D16-A29F4789B308Q34143718-0371151D-DC95-47C0-9DFD-AC5CF58DEB77Q34336984-AB7B9B1B-FB9B-495D-810F-52D7965D5118Q34370965-7C705C2A-1754-4D9D-AEB4-234552AE83E0Q34406470-D8E3A72A-0BA2-49D6-8B60-5118FE493682Q34474050-F70819D8-C381-4113-AEA7-424C42FFA9D3Q34620720-0C8DC4B0-DD0E-444E-B418-BD986853FAC3Q34858585-F14DA150-7A5C-4E5D-94DD-1E68FCE1B2F1Q34997620-BF12FF6D-FA06-4F3C-8A6D-2F9AD7EF0721Q35006102-41EF34E3-61FE-4D45-960C-1C4A09F8ACF0Q35191583-2FD40E24-F31C-4669-8941-FF820B7DD61FQ35215073-DA0D651A-9DBD-4232-ADCF-A5FA1DFFDC25Q35223008-B335609E-F82C-452C-84A5-72489DAC4D3CQ35237706-726EA277-B983-4381-8F16-E9F1E3417388Q35329148-5AEB1035-9EA1-4979-8F91-FE1C61652267Q35638036-F7E50D06-43B7-44FA-835A-212C69875B2DQ35750111-03A3FB62-4F36-4156-98ED-0668E43F1024Q35781691-05036616-C409-41BC-8A1A-19AE70EA6799Q35827821-3DFF3E71-872D-490A-81C7-56617EA50A23Q36018557-6D0B1C9A-70BA-4EC1-A477-E3C57068869DQ36063081-3778B1D9-8EB8-4D5A-9763-38A09AB05109Q36267948-2730F145-5A70-4EC9-917F-E1A22E51C849Q36328530-F4FABBFF-BF6D-45DA-BB21-141B6FA92287Q36377258-9E33BFF4-43ED-4DA7-84BC-D4C8787DEB36
P2860
Peroxisome proliferator-activated receptor-gamma calls for activation in moderation: lessons from genetics and pharmacology.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Peroxisome proliferator-activa ...... rom genetics and pharmacology.
@ast
Peroxisome proliferator-activa ...... rom genetics and pharmacology.
@en
type
label
Peroxisome proliferator-activa ...... rom genetics and pharmacology.
@ast
Peroxisome proliferator-activa ...... rom genetics and pharmacology.
@en
prefLabel
Peroxisome proliferator-activa ...... rom genetics and pharmacology.
@ast
Peroxisome proliferator-activa ...... rom genetics and pharmacology.
@en
P356
P1433
P1476
Peroxisome proliferator-activa ...... rom genetics and pharmacology.
@en
P2093
Chris Knouff
P304
P356
10.1210/ER.2003-0036
P50
P577
2004-12-01T00:00:00Z